Benign facial tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Aged between 18 and 60 years; 2.Clinically and postoperatively pathologically confirmed to have a facial benign tumor (such as melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment. 3.Voluntarily participate in this study and sign a written informed consent form. 4.Commit to complying with all procedures set in this study and cooperate in completing all follow-ups and data collection work.
Exclusion criteria
Exclusion criteria: 1.Clinically or postoperatively pathologically confirmed to have a facial malignant tumor. 2.Requires staged excision or wounds planned for secondary healing. 3.The surgical site is located on or adjacent to the mucosal surface. 4.Known history of allergies to medications, dressings, etc., to be used during or after surgery. 5.Presence of systemic diseases that severely affect wound healing (such as poorly controlled diabetes, immunodeficiency diseases, active infections, etc.). 6.Currently using medications that affect wound healing or scar formation (such as long-term use of glucocorticoids, immunosuppressants, etc.). 7.Pregnant or lactating women. 8.Refusal to sign the informed consent form, or anticipated difficulty in cooperating with study follow-ups and data collection. 9.Concurrent participation in other interventional clinical trials. 10.Other factors judged by the investigator as potentially interfering with study results or increasing participant risk.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stony Brook Scar Assessment Scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications related to wound healing;Skin Disease Quality of Life Index; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology